Building Resilient Families

October 11, 2023 updated by: Loma Linda University

A Multi-Component Intervention to Strengthen Families With Adverse Childhood Experiences (ACEs)

Prior research suggests that it is possible to improve health outcomes in children with ACEs through multi-component interventions. The challenge for most communities is that health and education systems are fragmented and fail to accommodate families based upon different levels of need. This study utilizes cross-sectoral partnerships to mobilize three vectors (pediatricians, community health workers and parenting educators) to optimize the delivery of vital information and resources to a diverse population of families with ACEs. All vectors are trained in an evidence-informed curriculum to strengthen families and build youth resilience. The study design is a randomized controlled trial of 340 families of children between the ages of 3 to 11 who are generally healthy and have recently seen a pediatrician for a well-child visit.

To evaluate the efficacy of this intervention, pediatric patients are invited to participate in repeat evaluations within 2 weeks, 3 months, 6 months, and 12 months after their well-child visit. The study will evaluate the following: 1) the association between Child-ACE scores and biomarkers of toxic stress at baseline in children age 3-11 years old; 2) whether the intervention reduces toxic stress and child health and psychosocial problems at follow-up for children with ACEs compared to usual well-child care for children with ACEs; and 3) the impact of mediating and moderating variables. These results will demonstrate that for families with ACEs the intervention will decrease toxic stress associated with ACEs, improve health outcomes, and reduce health disparities.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

340

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Loma Linda, California, United States, 92354
        • Recruiting
        • Loma Linda University
        • Contact:
          • Ariane Marie-Mitchell, MD, PhD, MPH
        • Principal Investigator:
          • Ariane Marie-Mitchell, MD, PhD, MPH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 9 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Ages 3-11
  • Seen for a well-child visit at a participating pediatric clinic

Exclusion Criteria:

  • < 3 years or >11 years of age
  • Significant congenital medical problems
  • Previous participation in parenting program (last 12 months)
  • Sibling enrollment in current study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Three-Tier Model
130 children with ACEs who received well-child care by a trained provider will be enrolled in this group.
Families in the intervention will be counseled by a pediatric provider about ACEs, resilience, stress management, and healthy relationships. Families will also be referred to community health workers and parenting educators.
No Intervention: Comparison Group
80 children without ACEs who received usual well-child care will be enrolled in this group.
No Intervention: Control Group
130 children with ACEs who received usual well-child care will be enrolled in this group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child Allostatic Load Index
Time Frame: Change between baseline and visit 4 (1-year post-enrollment)
A composite measurement that combines biometric data, neuroendocrine and immune markers, and executive function to determine whether the intervention lowers physiologic stress for children with ACEs. Each group will be followed over one year and growth curves will be analyzed to compare change in physiologic stress between baseline and final follow-up.
Change between baseline and visit 4 (1-year post-enrollment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pediatric Symptom Checklist (PSC)
Time Frame: Change between baseline and visit 4 (1-year post-enrollment)

The Pediatric Symptom Checklist is a psychosocial screen designed to indicate psychological impairment.

For participants ages 3-5, a total score of 24 indicates psychological impairment.

For participants ages 6-11, a total score of 28 indicates psychological impairment.

Change between baseline and visit 4 (1-year post-enrollment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ariane Marie-Mitchell, MD, PhD, MPH, Loma Linda University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2022

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

May 19, 2022

First Submitted That Met QC Criteria

May 19, 2022

First Posted (Actual)

May 24, 2022

Study Record Updates

Last Update Posted (Actual)

October 12, 2023

Last Update Submitted That Met QC Criteria

October 11, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adverse Childhood Experiences

Clinical Trials on Three-Tier Model

3
Subscribe